Sign in

CIK 0001725160

  • Non-accelerated filer
  • Smaller reporting company

Zentalis Pharmaceuticals, Inc.

Sign in to watch
Ticker
ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
823607803
Phone
+1 858-263-4333
Business address
10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
  1. 4 Open-market sale Chief Financial Officer sold 3,083 shares at an average $54.05 ($166,641)
  2. 4 Open-market sale President & CEO sold 26,794 shares at an average $54.03 ($1,447,679)
  3. 4 Open-market sale Chief Operating Officer sold 8,420 shares at an average $59.24 ($498,784)
  4. 4 Open-market sale President & CEO sold 26,794 shares at an average $59.32 ($1,589,506)
  5. 4 Open-market sale Chief Financial Officer sold 3,083 shares at an average $59.24 ($182,635)
  6. 4 Open-market sale Director sold 10,000 shares at an average $59.25 ($592,504)
  7. 4 Open-market sale Chief Operating Officer sold 3,810 shares at $45.00 ($171,450)
  8. 4 Open-market sale Director sold 28,369 shares at an average $43.40 ($1,231,238)
  9. 4 Open-market sale Chief Financial Officer sold 17,107 shares at an average $43.39 ($742,323)
  10. 4 Open-market sale Chief Operating Officer sold 25,211 shares at an average $43.40 ($1,094,032)
  11. 4 Open-market sale President & CEO sold 64,562 shares at an average $43.43 ($2,803,800)
  12. 4 Open-market sale Director sold 12,897 shares at $43.50 ($561,021)
  13. 4 Open-market sale Chief Operating Officer sold 4,210 shares at an average $43.45 ($182,917)
  14. 4 Open-market sale Chief Operating Officer sold 4,720 shares at $45.24 ($213,542)
  15. 4 Open-market sale Chief Operating Officer sold 3,700 shares at $45.07 ($166,747)
  16. 4 Open-market sale Chief Operating Officer sold 4,210 shares at $41.65 ($175,352)
  17. 4 Open-market sale President & CEO sold 26,794 shares at an average $41.70 ($1,117,225)
  18. 4 Open-market sale Director sold 10,000 shares at $41.69 ($416,858)
  19. 4 Open-market sale Chief Financial Officer sold 3,083 shares at $41.67 ($128,482)
  20. 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)

Page 10 of 13 · 252 filings